UBS Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144M | Sell |
1,836,495
-423,399
| -19% | -$33.1M | 0.02% | 587 |
|
|
2025
Q1 | $164M | Sell |
2,259,894
-426,151
| -16% | -$30.9M | 0.03% | 504 |
|
|
2024
Q4 | $199M | Buy |
2,686,045
+895,890
| +50% | +$66.3M | 0.04% | 420 |
|
|
2024
Q3 | $118M | Buy |
1,790,155
+132,265
| +8% | +$8.73M | 0.03% | 479 |
|
|
2024
Q2 | $153M | Buy |
1,657,890
+235,704
| +17% | +$21.8M | 0.04% | 353 |
|
|
2024
Q1 | $136M | Buy |
1,422,186
+2,982
| +0.2% | +$285K | 0.03% | 383 |
|
|
2023
Q4 | $108M | Sell |
1,419,204
-951,132
| -40% | -$72.5M | 0.03% | 398 |
|
|
2023
Q3 | $164M | Buy |
2,370,336
+302
| +0% | +$20.9K | 0.06% | 251 |
|
|
2023
Q2 | $224M | Buy |
2,370,034
+222,623
| +10% | +$21M | 0.08% | 212 |
|
|
2023
Q1 | $178M | Sell |
2,147,411
-162,808
| -7% | -$13.5M | 0.06% | 234 |
|
|
2022
Q4 | $172M | Sell |
2,310,219
-58,311
| -2% | -$4.35M | 0.06% | 241 |
|
|
2022
Q3 | $196M | Sell |
2,368,530
-145,446
| -6% | -$12M | 0.09% | 192 |
|
|
2022
Q2 | $239M | Buy |
2,513,976
+15,991
| +0.6% | +$1.52M | 0.1% | 180 |
|
|
2022
Q1 | $294M | Sell |
2,497,985
-362,168
| -13% | -$42.6M | 0.1% | 167 |
|
|
2021
Q4 | $371M | Buy |
2,860,153
+249,083
| +10% | +$32.3M | 0.11% | 143 |
|
|
2021
Q3 | $296M | Sell |
2,611,070
-141,213
| -5% | -$16M | 0.09% | 169 |
|
|
2021
Q2 | $285M | Buy |
2,752,283
+183,669
| +7% | +$19M | 0.09% | 174 |
|
|
2021
Q1 | $215M | Buy |
2,568,614
+271,440
| +12% | +$22.7M | 0.07% | 209 |
|
|
2020
Q4 | $210M | Buy |
2,297,174
+269,770
| +13% | +$24.6M | 0.07% | 196 |
|
|
2020
Q3 | $162M | Buy |
2,027,404
+196,543
| +11% | +$15.7M | 0.06% | 228 |
|
|
2020
Q2 | $127M | Sell |
1,830,861
-169,806
| -8% | -$11.7M | 0.05% | 249 |
|
|
2020
Q1 | $126M | Sell |
2,000,667
-126,801
| -6% | -$7.97M | 0.06% | 230 |
|
|
2019
Q4 | $165M | Sell |
2,127,468
-276,705
| -12% | -$21.5M | 0.06% | 232 |
|
|
2019
Q3 | $176M | Sell |
2,404,173
-44,430
| -2% | -$3.26M | 0.07% | 218 |
|
|
2019
Q2 | $151M | Sell |
2,448,603
-146,772
| -6% | -$9.04M | 0.06% | 243 |
|
|
2019
Q1 | $166M | Buy |
2,595,375
+140,085
| +6% | +$8.93M | 0.07% | 217 |
|
|
2018
Q4 | $125M | Sell |
2,455,290
-40,998
| -2% | -$2.09M | 0.06% | 245 |
|
|
2018
Q3 | $145M | Buy |
2,496,288
+61,797
| +3% | +$3.59M | 0.06% | 239 |
|
|
2018
Q2 | $118M | Buy |
2,434,491
+110,346
| +5% | +$5.35M | 0.05% | 277 |
|
|
2018
Q1 | $108M | Sell |
2,324,145
-251,961
| -10% | -$11.7M | 0.05% | 285 |
|
|
2017
Q4 | $96.8M | Buy |
2,576,106
+15,156
| +0.6% | +$569K | 0.04% | 316 |
|
|
2017
Q3 | $93.3M | Sell |
2,560,950
-174,333
| -6% | -$6.35M | 0.04% | 300 |
|
|
2017
Q2 | $108M | Buy |
2,735,283
+114,204
| +4% | +$4.5M | 0.06% | 271 |
|
|
2017
Q1 | $82.2M | Buy |
2,621,079
+428,577
| +20% | +$13.4M | 0.04% | 314 |
|
|
2016
Q4 | $68.5M | Buy |
2,192,502
+357,243
| +19% | +$11.2M | 0.04% | 341 |
|
|
2016
Q3 | $73.8M | Buy |
1,835,259
+132,855
| +8% | +$5.34M | 0.04% | 326 |
|
|
2016
Q2 | $56.6M | Buy |
1,702,404
+431,271
| +34% | +$14.3M | 0.04% | 361 |
|
|
2016
Q1 | $37.4M | Sell |
1,271,133
-35,271
| -3% | -$1.04M | 0.03% | 471 |
|
|
2015
Q4 | $34.4M | Buy |
1,306,404
+455,562
| +54% | +$12M | 0.02% | 528 |
|
|
2015
Q3 | $20.2M | Buy |
850,842
+63,840
| +8% | +$1.51M | 0.01% | 688 |
|
|
2015
Q2 | $18.7M | Sell |
787,002
-84,756
| -10% | -$2.01M | 0.01% | 801 |
|
|
2015
Q1 | $20.7M | Sell |
871,758
-14,556
| -2% | -$346K | 0.01% | 761 |
|
|
2014
Q4 | $18.8M | Buy |
+886,314
| New | +$18.8M | 0.01% | 792 |
|